Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Twist Bioscience Corporation’s reported figures.
Plus components not separately reported this period.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
FAQ
- What is Twist Bioscience Corporation's EBIT?
- Twist Bioscience Corporation (TWST) reported EBIT of -$45.86M in Q1 2026.
- How has Twist Bioscience Corporation's EBIT changed year-over-year?
- Twist Bioscience Corporation's EBIT decreased by 10.4% year-over-year, from -$41.56M to -$45.86M.
- What is the long-term trend for Twist Bioscience Corporation's EBIT?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's EBIT has grown at a -2.8% compound annual growth rate (CAGR), from -$152.73M to -$136.26M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Twist Bioscience Corporation's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude